[
  {
    "ts": null,
    "headline": "Disposable Endoscope Analysis Report 2025: A $4.95 Billion Market by 2029 - Aging Population and Growing Healthcare Expenditure Accelerate Shift Toward Disposable Endoscopic Solutions",
    "summary": "The global disposable endoscope market, valued at US$1.89 billion in 2023, is projected to reach US$4.95 billion by 2029, driven by rising hospital-acquired infections and demand for safer diagnostic tools. These sterile, single-use endoscopes reduce infection risks, catering to the GI, bronchoscopic, urologic, and arthroscopic applications. The market is set for a CAGR of 17%, with North America leading in 2023, and Asia Pacific poised for rapid growth. Key players like Boston Scientific and Ol",
    "url": "https://finnhub.io/api/news?id=4598743112d1d7d323f8f20944585054db530a60e5e6723975525bc24c41241a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771342800,
      "headline": "Disposable Endoscope Analysis Report 2025: A $4.95 Billion Market by 2029 - Aging Population and Growing Healthcare Expenditure Accelerate Shift Toward Disposable Endoscopic Solutions",
      "id": 139124084,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The global disposable endoscope market, valued at US$1.89 billion in 2023, is projected to reach US$4.95 billion by 2029, driven by rising hospital-acquired infections and demand for safer diagnostic tools. These sterile, single-use endoscopes reduce infection risks, catering to the GI, bronchoscopic, urologic, and arthroscopic applications. The market is set for a CAGR of 17%, with North America leading in 2023, and Asia Pacific poised for rapid growth. Key players like Boston Scientific and Ol",
      "url": "https://finnhub.io/api/news?id=4598743112d1d7d323f8f20944585054db530a60e5e6723975525bc24c41241a"
    }
  },
  {
    "ts": null,
    "headline": "Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $109",
    "summary": "Canaccord Genuity  analyst William Plovanic   maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $112 to $109.",
    "url": "https://finnhub.io/api/news?id=45824f5bc3515788c420b24ecaaacb8556fca2eae5d3ffdb30935102d7df8f65",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771329252,
      "headline": "Canaccord Genuity Maintains Buy on Boston Scientific, Lowers Price Target to $109",
      "id": 139135426,
      "image": "",
      "related": "BSX",
      "source": "Benzinga",
      "summary": "Canaccord Genuity  analyst William Plovanic   maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $112 to $109.",
      "url": "https://finnhub.io/api/news?id=45824f5bc3515788c420b24ecaaacb8556fca2eae5d3ffdb30935102d7df8f65"
    }
  }
]